Your browser doesn't support javascript.
loading
The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers.
Rubio-Rivas, Manuel; Mora-Luján, José M; Montero, Abelardo; Aguilar García, Josefa Andrea; Méndez Bailón, Manuel; Fernández Cruz, Ana; Oriol, Isabel; Teigell-Muñoz, Francisco-Javier; Dendariena Borque, Beatriz; De la Peña Fernández, Andrés; Fernández González, Raquel; Gil Sánchez, Ricardo; Fernández Fernández, Javier; Catalán, Marta; Cortés-Rodríguez, Begoña; Mella Pérez, Carmen; Montero Rivas, Lorena; Suárez Fuentetaja, Rebeca; Ternero Vega, Jara Eloísa; Ena, Javier; Martin-Urda Díez-Canseco, Anabel; Pérez García, Cristina; Varona, José F; Casas-Rojo, José Manuel; Millán Núñez-Cortés, Jesús.
Afiliación
  • Rubio-Rivas M; Department of Internal Medicine, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, Barcelona, Spain. mrubio@bellvitgehospital.cat.
  • Mora-Luján JM; Department of Internal Medicine, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, Barcelona, Spain.
  • Montero A; Department of Internal Medicine, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, Barcelona, Spain.
  • Aguilar García JA; Department of Internal Medicine, Costa del Sol Hospital, Marbella, Málaga, Spain.
  • Méndez Bailón M; Department of Internal Medicine, San Carlos University Hospital, Complutense University, Madrid, Spain.
  • Fernández Cruz A; Department of Internal Medicine, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.
  • Oriol I; Infectious Disease Unit, Department of Internal Medicine, Moisès Broggi Hospital, Sant Joan Despí, Barcelona, Spain.
  • Teigell-Muñoz FJ; Department of Internal Medicine, Infanta Cristina University Hospital, Parla, Madrid, Spain.
  • Dendariena Borque B; Department of Internal Medicine, San Pedro Hospital, Logroño, Spain.
  • De la Peña Fernández A; Department of Internal Medicine, Son Llàtzer University Hospital, Palma de Mallorca, Spain.
  • Fernández González R; Department of Internal Medicine, Ourense University Hospital, Ourense, Spain.
  • Gil Sánchez R; Department of Internal Medicine, La Fe Hospital, Valencia, Spain.
  • Fernández Fernández J; Department of Internal Medicine, Mataró Hospital, Mataró, Barcelona, Spain.
  • Catalán M; Department of Internal Medicine, Sagunto University Hospital, Sagunto, Valencia, Spain.
  • Cortés-Rodríguez B; Department of Internal Medicine, Alto Guadalquivir Hospital, Andújar, Jaén, Spain.
  • Mella Pérez C; Department of Internal Medicine, Ferrol Clinical University Hospital, El Ferrol, La Coruña, Spain.
  • Montero Rivas L; Department of Internal Medicine, Infanta Margarita Hospital, Cabra, Córdoba, Spain.
  • Suárez Fuentetaja R; Department of Internal Medicine, Monforte de Lemos Hospital, Monforte de Lemos, Lugo, Spain.
  • Ternero Vega JE; Department of Internal Medicine, Vírgen del Rocío University Hospital, Sevilla, Spain.
  • Ena J; Department of Internal Medicine, Marina Baixa Hospital, Villajoyosa, Alicante, Spain.
  • Martin-Urda Díez-Canseco A; Department of Internal Medicine, Palamós Hospital, Palamós, Girona, Spain.
  • Pérez García C; Department of Internal Medicine, Do Salnes Hospital, Vilagarcía de Arousa, Pontevedra, Spain.
  • Varona JF; Department of Internal Medicine, HM Montepríncipe University Hospital, Madrid, Spain.
  • Casas-Rojo JM; Department of Internal Medicine, Infanta Cristina University Hospital, Parla, Madrid, Spain.
  • Millán Núñez-Cortés J; Department of Internal Medicine, Infanta Cristina University Hospital, Parla, Madrid, Spain.
J Gen Intern Med ; 37(1): 168-175, 2022 01.
Article en En | MEDLINE | ID: mdl-34664188
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Corticoesteroides / Anticuerpos Monoclonales Humanizados / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Gen Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Corticoesteroides / Anticuerpos Monoclonales Humanizados / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Gen Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos